Screening of ATXN2 has also identified expansions >34 in rare cases of both ALS (Corrado et al., 2011; Ross et al., 2011; Van Damme et al., 2011) and FTD (Baumer et al., 2014; Fournier et al., 2018) although no signs of ataxia were reported and neuropathological examination confirmed a diagnosis of ALS. The gene discussed is ATXN2; the disease is frontotemporal dementia.